To participate, please contact: email@example.com or call, toll free, 855.582.3995
What happens when a person develops lung cancer? In the best of cases, the individual experiences a timely diagnosis and is counseled on all their treatment options, including:
Too often, however, we hear of people whose journey through the diagnosis was too long and challenging, or people who are given their diagnosis and never referred for treatment. In the worst occasions, some people are told, “Get your affairs in order,” or, “There’s nothing I can do for you.”
To address these issues head-on, Free to Breathe launched a project, dubbed "Improving Access to Treatment for Lung Cancer Patients" (AccessTLC). This two-part project will be implemented through a unique collaboration with:
We are working to document the time it takes for a person with lung cancer to go from diagnosis to treatment. We hope to better understand why any unnecessary delays to treatment occur so we can create effective programs for health care providers to improve patient care. We firmly believe with the treatment options we have available today, appropriate and timely referral to the right care should improve survival rates.
This study will measure the time it takes for lung cancer patients to be diagnosed and receive appropriate care in:
We will use the information learned in the first part of the project to launch comprehensive educational outreach activities to improve the care patients receive throughout the country.
AccessTLC has already developed learning activities designed specifically for primary care providers:
Primary care physicians in Wisconsin and North Carolina have already had access to live educational activities:“What Every Family Physician Should Know About Lung Cancer.” The presentations have teamed a lung cancer survivor with a medical oncologist to present a comprehensive overview of a real-life diagnosis of lung cancer. This program can be replicated for other medical education audiences; if you are interested in bringing the program to your area, please contact Free to Breathe CEO Regina Vidaver.
AccessTLC is supported by an educational grant from Pfizer.
@2014 Free To Breathe | All rights reserved.